Short Interest in Hillstream BioPharma, Inc. (NASDAQ:HILS) Decreases By 11.9%

Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report) was the target of a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 133,000 shares, a decline of 11.9% from the July 15th total of 150,900 shares. Approximately 2.2% of the company’s stock are sold short. […]

Related Keywords

Hillstream Biopharma ,Dawson James ,Nasdaq ,Hillstream Biopharma Inc ,Citadel Advisors ,Hillstream Biopharma Company Profile ,Geode Capital Management ,Get Free Report ,Biopharma Stock Down ,Capital Management ,Jane Street Group ,Hillstream Biopharma Daily ,Nasdaq Hils ,Vhils ,Medical ,Stocks ,Options ,Put ,Call ,